Prospective, single arm, monocentric clinical study to test NVDX3 in patients suffering from distal radius fracture. NVDX3 will be implanted during a single surgical intervention.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Safety: Serious Treatment-emergent Adverse Events (TEAEs) and NVDX3-related TEAEs
Timeframe: Between the beginning of the implant surgery (IS) and 12 months post-IS